|
⚲
|
| Keyboard |
| Yuan Qing Sarah
✚
|
|
|---|---|
| CIK # | 0001907487 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001907487] | |
| 4 | [0001907487] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Yuan Qing Sarah | |
| Sigilon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sigilon Therapeutics Inc SGTX
Common Stock
|
2023-08-11 | Disposed to issuer | 2,884 | ||
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-08-11 | Disposed to issuer | 8,846 | $0.75 | 6,634 |
|
Sigilon Therapeutics Inc SGTX
Common Stock
|
2023-07-27 | Option exercise | 2,884 | $19.24 | 55,488 |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-07-27 | Option exercise | 2,884 | $0.00 | |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-02-28 | Grant | 115,000 | $0.00 | |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2022-04-01 | Grant | 120,000 | $0.00 |